Recent Updates
Recently added Catalysts

Cefzil

Phase 1

Healthy | Small molecule | Other |Teva Pharmaceutical Industries Limited|Last Updated: Aug 20, 2024

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLED
Total Trials1
Total Enrollment38

FDA Designations

No designations recorded

Clinical trial landscape

Cefzil · 1 trial · 1 indication

Phase 1 1
NCT00840281Cefprozil 500 mg Tablets Under Fasting ConditionsHealthy
COMPLETED38 Analytics
PHASE1COMPLETED
Cefprozil 500 mg Tablets Under Fasting Conditions
Healthy
NCT0084028138
Unlock trial analytics

Study Endpoints

Primary Endpoints

Cmax (Maximum Observed Concentration)
Blood samples collected over a 12 hour period.

Bioequivalence based on Cmax.

AUC0-t (Area Under the Concentration-time Curve From Time Zero to Time of Last Measurable Concentration)
Blood samples collected over a 12 hour period.

Bioequivalence based on AUC0-t.

AUC0-inf (Area Under the Concentration-time Curve From Time Zero to Infinity)
Blood samples collected over a 12 hour period.

Bioequivalence based on AUC0-inf.

Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeOTHER

Treatment Arms

ArmTypeDescription
1EXPERIMENTAL -
2ACTIVE_COMPARATOR -

Interventions

NameTypeDescription
Cefzil® 500 mg tabletsDRUG1 x 500 mg, single-dose fasting
Cefprozil 500 mg TabletsDRUG1 x 500 mg, single-dose fasting
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: * Subjects selected for this study will be non-smokers at least 18 years of age. Subjects will have a BMI (body mass index) of 30 or less. * Each subject shall be given a general physical examination within 28 days of initiation of the study. Such examination includes, but is no...

Countries:United States
Unlock Eligibility Criteria

Frequently asked questions about Cefzil

What is Cefzil used for?

Cefzil is used for healthy volunteers in clinical trials. It is an investigational small molecule being studied for its effects in healthy individuals. The drug is currently in Phase 1 clinical development.

What does Cefzil target?

Cefzil does not have a specified molecular target or target class. It is a small molecule being studied in healthy volunteers, but its mechanism of action has not been detailed in the available information.

Who makes Cefzil?

Cefzil is being developed by Teva Pharmaceutical Industries Limited, a company traded on the stock exchange under the ticker symbol TEVA. Teva is responsible for the clinical development of this investigational drug.

What phase is Cefzil in?

Cefzil is in Phase 1 clinical development. It is an investigational drug, meaning it has not been approved by regulatory authorities and is still undergoing clinical trials to evaluate its safety and effects in healthy volunteers.

What clinical trials is Cefzil in?

Cefzil has one completed clinical trial, identified as NCT00840281, titled 'Cefprozil 500 mg Tablets Under Fasting Conditions'. This Phase 1 study enrolled 38 healthy volunteers in the United States and was an active-controlled, randomized trial.

Is Cefzil the same as cefprozil?

Cefzil is the brand name for the drug cefprozil. The clinical trial NCT00840281 studied cefprozil 500 mg tablets, indicating that Cefzil and cefprozil refer to the same medication.